SCHEMBL206738

SCHEMBL206738

Cc1ccc(CC2(N(C)C)CCC(NC(=O)CCC(=O)NCCc3ccccc3Cl)CC2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
GAA P10253 2/20 0.40
POLB P06746 2/20 0.40
ALDH1A1 P00352 2/20 0.40
HPGD P15428 1/20 0.40
USP2 O75604 1/20 0.39
SIGMAR1 Q99720 1/20 0.38
LMNA P02545 1/20 0.38
KMT2A Q03164 1/20 0.38
HTT P42858 1/20 0.38
ATM Q13315 1/20 0.38
PLAAT3 P53816 1/20 0.37
PLAAT5 Q96KN8 1/20 0.37
PLAAT2 Q9NWW9 1/20 0.37
PLAAT4 Q9UL19 1/20 0.37
MCHR1 Q99705 1/20 0.37
TP53 P04637 1/20 0.37
OPRM1 P35372 1/20 0.37
OPRL1 P41146 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL205931 0.90 TSHR (0.40) TSHRSMN1; SMN2GAAPOLBALDH1A1
SCHEMBL208514 0.89 TSHR (0.43) TSHRSMN1; SMN2ALDH1A1SIGMAR1KMT2A
SCHEMBL208660 0.88 PLAAT3 (0.46) TSHRSMN1; SMN2PLAAT3PLAAT5PLAAT2
SCHEMBL208794 0.88 ALDH1A1 (0.44) SMN1; SMN2GAAPOLBALDH1A1HPGD
SCHEMBL206456 0.88 POLB (0.45) TSHRSMN1; SMN2GAAPOLBALDH1A1
SCHEMBL208300 0.87 LMNA (0.50) TSHRPOLBALDH1A1LMNAKMT2A
SCHEMBL206304 0.85 CNR1 (0.44) SMN1; SMN2ALDH1A1SIGMAR1LMNAKMT2A
SCHEMBL205912 0.83 HPGD (0.47) TSHRPOLBALDH1A1HPGDLMNA
SCHEMBL4075006 0.83 KMT2A (0.46) GAAPOLBALDH1A1KMT2AHTT
SCHEMBL4084112 0.83 HPGD (0.45) ALDH1A1HPGDLMNAKMT2APLAAT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088763-B2 e.g. N-[1-(2,6-dichloro-benzyl)-pyrrolidin-3-yl]-N'-[4-dimethylamino-4-(4-methyl-benzyl)-cyclohexyl]-succinamide; noradrenaline and serotonin reuptake ihibitor; opioid ORL-1 receptor ligand; analgesic, antidepressant, anxiolytic agent, neurodegenerative diseases GRUENENTHAL GMBH (DE) 2012-01-03 US claimed
EP-1745010-B1 SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES GRUENENTHAL GMBH (DE) 2009-08-05 EP claimed
US-20070112007-A1 Cyclohexyl-1, 4-diamine compounds GRUENENTHAL GMBH (DE) 2007-05-17 US claimed
US-8088763-B2 e.g. N-[1-(2,6-dichloro-benzyl)-pyrrolidin-3-yl]-N'-[4-dimethylamino-4-(4-methyl-benzyl)-cyclohexyl]-succinamide; noradrenaline and serotonin reuptake ihibitor; opioid ORL-1 receptor ligand; analgesic, antidepressant, anxiolytic agent, neurodegenerative diseases GRUENENTHAL GMBH (DE) 2012-01-03 US disclosed
EP-1745010-B1 SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES GRUENENTHAL GMBH (DE) 2009-08-05 EP disclosed
US-20070112007-A1 Cyclohexyl-1, 4-diamine compounds GRUENENTHAL GMBH (DE) 2007-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112007-A1 Cyclohexyl-1, 4-diamine compounds PKD1, DDC, DPYD TSHR 4464/4885SMN1; SMN2 1061/4885GAA 20/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.